Interestingly, it has been reported the presence of auto-antibodies against galectin-3 in the sera from patients with secondary progressive multiple sclerosis (SPMS), which could be partly responsible for the progressive damage to the blood-brain barrier (BBB) associated with MS [12]. This evidence concerns the gene LGALS3 and myeloid sarcoma.